Ask AI

Diabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies

This activity is available for 0.50 CME/CE credit(s).

Released: March 20, 2026

Expiration: March 19, 2027

See Activity Collection

Maria R. is a 56-year-old woman with a 12-year history of type 2 diabetes who remains above glycemic targets despite maximally tolerated oral therapy and a GIP/GLP-1 receptor agonist. She experiences persistent fasting hyperglycemia and feels overwhelmed by the daily demands of diabetes management. While she values independence and predictable routines, Maria is anxious about starting insulin, viewing it as a sign of disease progression and worrying about making mistakes. She is also curious but uncertain about new and emerging once-weekly basal insulin options.

This case highlights a common clinical scenario in which patient-centered counseling is essential to address emotional and practical barriers to insulin initiation. Learn how to engage patients like Maria using empathetic, evidence-based communication strategies, assess readiness for therapy, and clearly explain once-weekly insulin concepts to support shared decision-making and improve confidence in diabetes self-management.

Weekly Insulin Optimization

Pre Assessment: Prepare to Meet Your Patient

Assess your current knowledge and clinical approach before meeting your patient.
1.

A 58-year-old patient with type 2 diabetes is being considered for transition from daily basal insulin to a once-weekly basal insulin formulation. Which action by a certified diabetes care and education specialist (CDCES) is MOST likely to optimize patient outcomes during this transition?